MLKL and lymphoma: To study the role of Ripk3-Mlkl signaling in IR-induced leukemia/lymphoma development, we treated WT, Ripk3−/−, and Mlkl−/− mice with 1.75 Gy × 4 IR and monitored for disease development and mouse survival.